The current PE ratio of PRGO can't be determined, as the TTM EPS of -$0.09 is negative. PERRIGO's last PE ratio on record was 30.65 in June 2020.
The mean historical PE ratio of PERRIGO over the last ten years is 80.06. In the past ten years, PRGO's PE ratio was at its highest in the Dec 2015 quarter at 249.48, with a price of $144.7 and an EPS of $0.58. The Sep 2019 quarter recorded the bottom point at 30.38, with a price of $54.98 and an EPS of $1.81.
Maximum annual increase: 181.28% in 2014
Maximum annual decrease: -60.69% in 2018
| Year | PE ratio | Change |
|---|---|---|
| 2023 | N/A | N/A |
| 2022 | N/A | N/A |
| 2021 | N/A | N/A |
| 2020 | N/A | N/A |
| 2019 | 48.28 | 18.36% |
| 2018 | 40.79 | -60.69% |
| 2017 | 103.76 | N/A |
| 2016 | N/A | N/A |
| 2015 | 196.44 | 171.85% |
| 2014 | 72.26 | 181.28% |
| Stock name | PE ratio | Market cap |
|---|---|---|
| UTHR UNITED THERAPEUTICS Corp | 11.74 | $11.64B |
| JAZZ Jazz Pharmaceuticals plc | 21.03 | $6.93B |
| TECH BIO-TECHNE Corp | 54.82 | $12.15B |
| CTLT Catalent Inc | N/A | $10.21B |
| PRGO PERRIGO Co plc | N/A | $4.44B |
The current price to earnings ratio of PRGO can't be calculated, as its EPS of -$0.09 is negative.
As an average over the last 5 years, PRGO stock has a PE ratio of 43.38.
In the last ten years, the Dec 2015 quarter recorded the highest quarterly PE ratio at 249.48.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.